Addus HomeCare Corporation $ADUS Shares Sold by NFJ Investment Group LLC

NFJ Investment Group LLC cut its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 99.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 295 shares of the company’s stock after selling 85,161 shares during the period. NFJ Investment Group LLC’s holdings in Addus HomeCare were worth $32,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. TimesSquare Capital Management LLC grew its holdings in shares of Addus HomeCare by 6.2% in the third quarter. TimesSquare Capital Management LLC now owns 418,348 shares of the company’s stock valued at $49,361,000 after purchasing an additional 24,301 shares in the last quarter. Burney Co. acquired a new position in shares of Addus HomeCare in the fourth quarter valued at approximately $1,841,000. Public Sector Pension Investment Board grew its holdings in shares of Addus HomeCare by 14.4% in the third quarter. Public Sector Pension Investment Board now owns 70,827 shares of the company’s stock valued at $8,357,000 after purchasing an additional 8,893 shares in the last quarter. Capital Research Global Investors grew its holdings in shares of Addus HomeCare by 9.0% in the third quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock valued at $141,772,000 after purchasing an additional 99,262 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of Addus HomeCare by 2.9% in the third quarter. Vanguard Group Inc. now owns 1,298,104 shares of the company’s stock valued at $153,163,000 after purchasing an additional 36,674 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $93.28 on Monday. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.08. Addus HomeCare Corporation has a 52 week low of $87.95 and a 52 week high of $124.43. The stock has a market capitalization of $1.74 billion, a PE ratio of 17.24, a price-to-earnings-growth ratio of 1.28 and a beta of 0.89. The firm has a 50 day moving average of $93.73 and a two-hundred day moving average of $103.22.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The company had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. During the same quarter in the previous year, the business posted $1.42 EPS. The firm’s revenue was up 7.7% on a year-over-year basis. As a group, research analysts expect that Addus HomeCare Corporation will post 6.24 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ADUS has been the subject of a number of research reports. Citizens Jmp restated a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Monday, May 18th. Wall Street Zen cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. Weiss Ratings cut shares of Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 22nd. Barclays dropped their price objective on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a report on Friday, May 15th. Finally, KeyCorp reiterated an “overweight” rating on shares of Addus HomeCare in a report on Wednesday, February 25th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $131.00.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.